An update on pediatric bronchiectasis
Danielle F Wurzel, Anne B Chang
EXPERT REVIEW OF RESPIRATORY MEDICINE | TAYLOR & FRANCIS LTD | Published : 2017
INTRODUCTION: The prevalence and awareness of bronchiectasis not related to cystic fibrosis (CF) is increasing and it is now recognized as a major cause of respiratory morbidity, mortality and healthcare utilization worldwide. The need to elucidate the early origins of bronchiectasis is increasingly appreciated and has been identified as an important research priority. Current treatments for pediatric bronchiectasis are limited to antimicrobials, airway clearance techniques and vaccination. Several new drugs targeting airway inflammation are currently in development. Areas covered: Current management of pediatric bronchiectasis, including discussion on therapeutics, non-pharmacological inter..View full abstract
Awarded by NHMRC
A. Chang is supported by a NHMRC practitioner fellowship [grant 1058213].